Os copolímeros de 3-hidroxibutirato e 3-hidroxihexanoato (P3HB-co-3HHx) são da família dos polihidroxialcanoatos (PHA), materiais termoplásticos e biodegradáveis acumulados por bactérias a partir de fontes de carbono renováveis. O P3HB-co-3HHx desperta interesse industrial para frações de 3HHx menores que 20 mol%, assemelhando-se ao polietileno de baixa densidade. Neste projeto, criou-se um sistema genético para controlar a composição do copolímero P3HB-co-3HHx pela indução de genes da biossíntese de precursores 3HB. Baseado no promotor lac foram construídas cinco versões do plasmídeo de controle de copolímero (pCC) utilizando o promotor Lac. Porém, mesmo com a versão mais aprimorada, não foi possível o controle de composição de P3HB-co-3HHx em Pseudomonas sp. LFM461. Através de experimentos de atividade enzimática e RT-qPCR do cDNA do gene phaA e phaB, foi possível indicar que o problema está na impossibilidade do promotor Lac de promover expressão dos genes de biossíntese de 3HB presentes nos pCC. / Polyhydroxyalkanoates (PHA) are polyesters material accumulated by bacteria which has thermoplastic and biodegradable proprieties and can be produced from renewable feedstocks. Copolymers of 3-hydroxybutirate and 3-hydroxyhexanoate (P3HB-co¬-3HHx) which contain less than 20mol% of 3HHx have being researched for its industrial proprieties. Recently, our laboratory has been researching a Pseudomonas sp. strain, LFM461, which can produce high 3HHx content when hosting PHA biosynthesis genes from Aeromonas. In this project, it was design a genetic system for control of P3HB-co-3HHX composition through induction of 3HB monomers biosynthesis. Thus, five versions of a copolymer control plasmid (pCC) was built based on Lac promoter. However, even through improvements on stability and expression profile of pCC it was not possible to stablish an assay of successful PHA composition control in Pseudomonas sp. LFM461. By enzymatic activity and RT-qPCR of cDNA experiments we have indications of problems of Lac promoter on driving the expression of 3HB genes in pCC.

Copolímeros de e-caprolactona e l,l-dilactídeo têm sido investigados com a finalidade de desenvolver materiais biodegradáveis para aplicações médicas. As sínteses dos homopolímeros e copolímeros de epsilon-caprolactona e l,l-dilactídeo por abertura de anel e polimerização em massa transcorreram a 120oC sob atmosfera de nitrogênio, usando o octanoato de estanho como iniciador. A composição dos copolímeros variou de 5,90% a 97,30% em massa de l,l-dilactídeo. As massas molares dos polímeros sintetizados foram determinadas por viscosimetria capilar e cromatografia de permeação em gel (GPC). A composição dos copolímeros foi determinada por RMN de 13C. As propriedades térmicas e mecânicas foram avaliadas por DSC e DMTA. O grau de cristalinidade e as fases cristalinas dos copolímeros foram determinados por difração de raios X (WAXS). Foram observadas altas taxas de conversão de monômeros para os homopolímeros e para os copolímeros Co60 ao Co90 (taxas de 70-80%). Os homopolímeros e copolímeros sintetizados apresentaram altas massas molares (M w até 106.500 g/mol para os copolímeros) e moderada polidispersidade (1,50). As análises de RMN de 13C demonstraram a predominância da formação de copolímeros estatísticos e a ausência da transesterificação durante a polimerização em massa. As propriedades dinâmico-mecânicas foram fortemente dependentes da estrutura cristalina e do grau de cristalinidade dos copolímeros. Os copolímeros sintetizados apresentaram propriedades mecânicas variando do flexível ao rígido termoplástico. Os copolímeros com composição próxima a equimolar (Co30 ao Co40) apresentaram os mais baixos graus de cristalinidade (13 a 15%) e, por conseqüência, apresentaram maior taxa de degradação (20% em 408 horas para o Co40), em comparação com os demais copolímeros. / Copolymers of epsilon-caprolactone with l,l-lactide have been investigated in order to develop biodegradable materials for medical applications. The synthesis of homopolymers and copolymers of e-caprolactone with l,l-lactide by ring-opening bulk polymerization was performed using stannous octoate as initiator at 120 ºC under nitrogen atmosphere. The copolymers composition was varied from 5.90 to 97.30 % in mass of l,l-lactide. The molecular weight of synthesized polymers were determined by viscometry and GPC. The copolymers composition was determined by 13C NMR. Thermal and mechanical properties have been evaluated by DSC and DMTA. The degree of crystallinity and the crystalline phase of copolymers were determined by WAXS. High conversion was observed for homopolymers and copolymers Co60 to Co90 of l,l-lactide (70-80%). The homopolymers and copolymers presented hight molecular weight (M w up to 106,500 g/mol for copolymers) and low polydispersivity (1,50). The analyses by 13C- NMR spectroscopy have shown the predominance of statistical copolymers formation and the transesterification reaction did not occur during the bulk polymerization. Thermal and mechanical properties were dependent on the crystalline phase and of the degree of crystallinity. The synthesized copolymers presented mechanical properties from rubbery to stiff thermoplastics. The copolymers with equimolar composition presented low degree of crystallinity (13 ? 15%) and higher degradation (20% during 408 hours for Co40).

<p>Date: 6/16/2008</p><p>Institution: School of Sustainable Development of Society and Technology, Mälardalen University, Västerås (Sweden)</p><p>Authors:</p><p>Brüning, Andrea</p><p>830111</p><p>Västerås</p><p>Curtolo,Anna</p><p>820517</p><p>Västerås</p><p>Tutor: Tobias Eltebrandt</p><p>Title: A Study of Switch Pac: what would be the efficient ways for Switch Pac to increase potential demand and capitalize on green attitudes and behavior in the Swedish market?</p><p>Problem: What would be the efficient ways for Switch Pac to increase potential demand and capitalize on green attitudes and behavior in the Swedish market?</p><p>Purpose: The aim of our project is to see the potential of Switch Pac’s oxo-biodegradable plastic bags on the Swedish market by capitalize on green attitudes and behaviour.</p><p>Method: The report is based on primary data collected through questionnaires (end consumer/ B2B customers). For the investigation of Switch Pac’s macro- and microenvironment secondary data was used (books, journals, newspaper and the Internet)</p><p>Conceptual Framework: The conceptual framework consists of certain models to investigate the following topics:</p><p>Consumer behavior</p><p>AIDA-Model</p><p>STP-Model</p><p>Switch Pac´s business environment</p><p>PESTEL</p><p>Conclusion/ Recommendations: In our conclusion based on our frameworks PESTEL, AIDA and STP we concluded that peoples’ awareness regarding environmental friendly plastic bags are not very high based on our questionnaire. The efficient ways for Switch Pac to increase potential demand is to target the customer in the age range from 20 – 49 years and cooperate with supermarkets and (department) stores. Furthermore, Switch Pac needs to position its products in the consumers mind through create brand awareness by using certain elements of the marketing mix model.</p>

<p>Most pathogens enter the body via mucosal surfaces. In contrast to parenterally administered vaccination, mucosal vaccination has the advantage of eliciting both a systemic and a local mucosal immune response. An oral biodegradable adjuvant with these features would have great potential. </p><p>This thesis has focused on the development of a new oral vaccine against diphtheria. Biodegradable polyacryl starch microparticles were used as a mucosal adjuvant. Diphtheria toxin or cross-reacting material of diphtheria toxin (CRM197) was covalently conjugated to the microparticles and fed to mice by oral gavage. Formaldehyde treatment was also studied as a means of either detoxifying (diphtheria toxin) or stabilising (CRM197) these formulations. All formulations given to mice orally or parenterally, but not intranasally, induced a strong systemic immune response and diphtheria toxin neutralising antibodies. Only formulations administered orally induced a mucosal IgA response as well. </p><p>The non-toxic recombinant protein CRM197 proved to be a promising antigen candidate in an oral diphtheria vaccine when conjugated to the microparticles. Mild treatment of CRM197 with formaldehyde before conjugation to the starch microparticles potentiated the immunogenicity of the formulation. However, no immune response was detected in healthy volunteers after administration of this vaccine in a phase I trial. The possible reasons for the difference in response between mouse and man are discussed.</p><p>The use of cDNA expression macro array technology was also evaluated as a tool in vaccine-related research. Tetanus toxoid and aluminium phosphate were used as model parenteral antigen and adjuvant. It was concluded that the antigen modulates the molecular mechanisms of the aluminium phosphate adjuvant to a greater extent than previously recognised.</p>

Most pathogens enter the body via mucosal surfaces. In contrast to parenterally administered vaccination, mucosal vaccination has the advantage of eliciting both a systemic and a local mucosal immune response. An oral biodegradable adjuvant with these features would have great potential. This thesis has focused on the development of a new oral vaccine against diphtheria. Biodegradable polyacryl starch microparticles were used as a mucosal adjuvant. Diphtheria toxin or cross-reacting material of diphtheria toxin (CRM197) was covalently conjugated to the microparticles and fed to mice by oral gavage. Formaldehyde treatment was also studied as a means of either detoxifying (diphtheria toxin) or stabilising (CRM197) these formulations. All formulations given to mice orally or parenterally, but not intranasally, induced a strong systemic immune response and diphtheria toxin neutralising antibodies. Only formulations administered orally induced a mucosal IgA response as well. The non-toxic recombinant protein CRM197 proved to be a promising antigen candidate in an oral diphtheria vaccine when conjugated to the microparticles. Mild treatment of CRM197 with formaldehyde before conjugation to the starch microparticles potentiated the immunogenicity of the formulation. However, no immune response was detected in healthy volunteers after administration of this vaccine in a phase I trial. The possible reasons for the difference in response between mouse and man are discussed. The use of cDNA expression macro array technology was also evaluated as a tool in vaccine-related research. Tetanus toxoid and aluminium phosphate were used as model parenteral antigen and adjuvant. It was concluded that the antigen modulates the molecular mechanisms of the aluminium phosphate adjuvant to a greater extent than previously recognised.

Lymph node metastasis is a critical prognostic factor for lung cancer. Effective therapy to control lymphatic metastasis may improve survival. The work described in this thesis focuses on the development of a microparticulate lymphatic targeting system, which can be applied as an adjuvant therapy in the control of lymphatic metastasis in lung cancer. The study shows that intrapleural administered colloidal particulates are predominantly taken up by regional lymphatic tissue in rat models including healthy rats, rats bearing orthotopic lung tumours and rats following pneumonectomy. The effect of particle size on lymphatic particle distribution was examined by intrapleural administration of 111In-aminopolystyrene beads. Approximately 2 µm is a suitable size for intrapleural lymphatic targeting. Biodegradable polylactide-co-glycolide (PLGA) microparticles containing the anticancer agent paclitaxel (PTX) were subsequently formulated in the desired size by spray drying. PLGA-PTX microspheres were incorporated into a biodegradable and biocompatible gelatin sponge matrix to form an implantable lymphatic targeted drug delivery system. The system was characterized in vitro and its lymphatic targeting ability was examined in vivo. Fluorescence labeled microspheres embedded within the sponge were selectively taken up by regional lymphatics as the sponge matrix disintegrated following intrapleural implantation. A pharmacokinetic study showed that the total PTX exposure in lymphatic tissue was dramatically higher than that achieved through intravenous administration. The peak plasma drug concentration, which governs systemic toxicity, was significantly reduced. The low but persistent detection of plasma PTX indicates that PTX was control released from the system after intrapleural implantation. In a therapeutic efficacy study performed in the H460 orthotopic lung cancer model, gelatin sponges containing PLGA-PTX microspheres were placed in the pleural cavity as an adjuvant treatment after surgical resection of the primary lung tumour. Trans-lymphatic chemotherapy resulted in a significantly lower incidence of lymphatic tumour recurrence (20%) compared to no treatment and placebo control animals (100%). PLGA-PTX microspheres were seen in regional lymphatic tissue over 4 weeks after the sponge placement. It is concluded that the trans-lymphatic targeting drug delivery system described in this thesis may improve the control of lymphatic metastasis in lung cancer.

Lymph node metastasis is a critical prognostic factor for lung cancer. Effective therapy to control lymphatic metastasis may improve survival. The work described in this thesis focuses on the development of a microparticulate lymphatic targeting system, which can be applied as an adjuvant therapy in the control of lymphatic metastasis in lung cancer. The study shows that intrapleural administered colloidal particulates are predominantly taken up by regional lymphatic tissue in rat models including healthy rats, rats bearing orthotopic lung tumours and rats following pneumonectomy. The effect of particle size on lymphatic particle distribution was examined by intrapleural administration of 111In-aminopolystyrene beads. Approximately 2 µm is a suitable size for intrapleural lymphatic targeting. Biodegradable polylactide-co-glycolide (PLGA) microparticles containing the anticancer agent paclitaxel (PTX) were subsequently formulated in the desired size by spray drying. PLGA-PTX microspheres were incorporated into a biodegradable and biocompatible gelatin sponge matrix to form an implantable lymphatic targeted drug delivery system. The system was characterized in vitro and its lymphatic targeting ability was examined in vivo. Fluorescence labeled microspheres embedded within the sponge were selectively taken up by regional lymphatics as the sponge matrix disintegrated following intrapleural implantation. A pharmacokinetic study showed that the total PTX exposure in lymphatic tissue was dramatically higher than that achieved through intravenous administration. The peak plasma drug concentration, which governs systemic toxicity, was significantly reduced. The low but persistent detection of plasma PTX indicates that PTX was control released from the system after intrapleural implantation. In a therapeutic efficacy study performed in the H460 orthotopic lung cancer model, gelatin sponges containing PLGA-PTX microspheres were placed in the pleural cavity as an adjuvant treatment after surgical resection of the primary lung tumour. Trans-lymphatic chemotherapy resulted in a significantly lower incidence of lymphatic tumour recurrence (20%) compared to no treatment and placebo control animals (100%). PLGA-PTX microspheres were seen in regional lymphatic tissue over 4 weeks after the sponge placement. It is concluded that the trans-lymphatic targeting drug delivery system described in this thesis may improve the control of lymphatic metastasis in lung cancer.

Aliphatic polyesters such as polycaprolactone and polylactide have received more attention in recent years for their use in biomedical applications because of their biodegradable nature. These polymers are often synthesized using homogeneous metal complexes. Unfortunately, using homogeneous metals as catalysts leads to metal contamination in the product polymer, a result which is highly undesirable in a polymer intended for biomedical use. More recent work has shown that these polymers can be synthesized using homogeneous metal-free complexes. These catatlysts are generally less active than metal catalysts, and although they do not contaminate the polymer with metal residue, they are still difficult to recover and hence recycle for further use. In this work, we attempted to create a metal-free, silica-supported catalyst for use in the synthesis of polycaprolactone or polylactide. Ultimately, n-propylsulfonic acid-functionalized porous and nonporous silica materials are evaluated in the ring-opening polymerization of epsilon-caprolactone. All catalysts allow for the controlled polymerization of the monomer, producing polymers with controlled molecular weights and narrow polydispersities. Polymerization rates are low, with site-time-yields generally one to three orders of magnitude lower than metal-based systems. The catalysts are easily recovered from the polymerization solution after use and are shown to contain significant residual adsorbed polymer. Solvent extraction techniques are useful for removing most of the polymer, although the extracted solids are not effective catalysts in recycle experiments. These new materials represent a green alternative to traditional metal-based catalysts, as they are recoverable and leave no metal residues in the polymer.

The role of matrix metalloproteinase (MMP)-9 and processing conditions of biodegradable polymer scaffolds has been investigated to optimize engineering vascular constructs. For a small diameter vascular construct, uniform 10 mm thickness of highly porous scaffolds were developed using a computer-controlled knife coater and exploiting phase transition properties of salts. The comparative study of fast vs. slow degrading three-dimensional scaffolds using a fast degrading poly D, L-lactic-glycolic acid co-polymer (PLGA) and a slow degrading poly e-caprolactone (PCL) indicated that fast degradation negatively affects cell viability and migration into the scaffold in vitro and in vivo, which is likely due to the fast polymer degradation mediated acidification of the local environment. MMP-9 was crucial for collagen remodeling process by smooth muscle cells (SMC). MMP-9 deficiency dramatically decreased inflammatory cell invasion as well as capillary formation within the scaffolds implanted in vivo. This study reports that the angiogenic response developed within the scaffolds in vivo was related to the presence of inflammatory response. Combinatorial polymer libraries fabricated from blended PLGA and PCL and processed at gradient annealing temperatures were utilized to investigate polymeric interactions with SMC. Surface roughness was also found to correlate with SMC adhesion. SMC aggregation, proliferation, and protein production, were highest in regions that exhibited increased surface roughness, reduced hardness, and decreased crystallinity of the PCL-rich phases. This study revealed a previously unknown processing temperature and blending compositions for two well-known polymers, which optimized SMC interactions.

Osteomyelitis is an infection of bone or bone marrow, usually caused by pyogenic bacteria. It can cultivate by hematogen way or it can cultivate by the help of local soft tissue infection. Osteomyelitis often requires prolonged antibiotic therapy and surgery. But for therapy / antibiotic must reach to effective dose in the bone. So that / for prevention and treatment of osteomyelitis controlled antibiotic release systems can be used. These systems have been developed to deliver antibiotics directly to infected tissue. As a carrier material / polymers are widely use. Polymer can be biodegradable or non biodegradable. The advantage of biodegradable polymers is / you do not need a second surgery for the removal of the carrier material from the body. In this study / vancomycin loaded PLLA/TCP composites were developed and characterized to treat implant related chronic osteomyelitis in experimental rat osteomyelitis model. Some of the composites were prepared by coating the vancomycin loaded composites with PLLA to observe the difference between the coated and uncoated composites. Also, some composites were developed free from the vancomycin to determine the biocompatibility of the composite for the bone tissue. The coating extended the release of the vancomycin up to 5 weeks and changed the surface morphology of the composites. According to the cell culture studies, vancomycin loaded PLLA/TCP composites promoted cell adhesion, cell proliferation and mineralization so / the composite was biocompatible with bone tissue. Radiological and microbiological evaluations showed that vancomycin loaded and coated vancomycin loaded PLLA/TCP composites inhibited MRSA proliferation and treat implant related chronic osteomyelitis.